Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase

Vaccine

Volumn 18, Issue 28, 2000, Pages 3214-3222

  Chen, Ze ^a,b   Kadowaki, Shin Etsu ^a   Hagiwara, Yukari ^a   Yoshikawa, Tomoki ^a   Matsuo, Kazutoshi ^a   Kurata, Takeshi ^a   Tamura, Shin Ichi ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b HUNAN NORMAL UNIVERSITY   (China)

Author keywords

DNA vaccine; Influenza; Neuraminidase

Indexed keywords

CROSS REACTING ANTIBODY; DNA VACCINE; SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CROSS RESISTANCE; DNA TRANSFER; ELECTROPORATION; GENE GUN; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; VACCINATION; VIRUS TITRATION;

EID: 0034257192     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00149-3     Document Type: Article

References (41)

1. Murphy B.R., Webster R.G. Orthomyxoviruses. Field B.N., Knipe D.M., Hoeley P.M., Chanock R.M., Hirsch M.S., Melnick J.L., Monath T.P., Roizman B., Straus S.E. Virology. 1996;1397-1445 Lippincott Raven, Philadelphia/New York.
2. Powers D.C., Kilbourne E.D., Johansson B.E. Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults. Clin. Diagn. Lab. Immunol. 3:1996;511-516.
3. Keitel W.A., Cate T.R., Atmar R.L., Turner C.S., Nino D., Dukes C.M., Six H.R., Couch R.B. Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clin. Diagn. Lab. Immunol. 3:1996;507-510.
4. Lakey D.L., Treanor J.J., Betts R.F., Smith G.E., Thompson J., Sannella E., Reed G., Wilkinson B.E., Wright P.F. Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J. Infect. Dis. 174:1996;838-841.
5. Deroo T., Jou W.M., Fiers W. Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine. 14:1996;561-569.
6. Johansson B.E., Matthews J.T., Kilbourne E.D. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine. 16:1998;1009-1015.
7. Johansson B.E. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine. 17:1999;2073-2080.
8. Hoskins T.W., Davies J.R., Smith A.J., Allchin A., Miller C.L., Pollock T.M. Influenza at Christ's Hospital: March, 1974. Lancet. 1:1976;105-108.
9. Meyer HJ, Hopps HE, Parkman PD, Ennis FA, Review of existing vaccines for influenza, Am. J. Clin. Pathol. 1978;146-52.
10. Couch R.B., Kasel J.A. Immunity to influenza in man. Annu. Rev. Microbiol. 37:1983;529-549.
11. Wilson I.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Ann. Rev. Immunol. 8:1990;737-771.
12. Kilbourne E.D., Johansson B.E., Grajower B. Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. Proc. Natl Acad. Sci. USA. 87:1990;786-790.
13. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein [see comments]. Science. 259:1993;1745-1749.
14. Robinson H.L., Hunt L.A., Webster R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine. 11:1993;957-960.
15. Ulmer J.B., Deck R.R., DeWitt C.M., Friedman A., Donnelly J.J., Liu M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine. 12:1994;1541-1544.
16. Webster R.G., Fynan E.F., Santoro J.C., Robinson H. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine. 12:1994;1495-1498.
17. Robinson HL, Boyle CA, Feltquate DM, Morin MJ, Santoro JC, Webster RG, DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs, J. Infect. Dis. 1997;176 Suppl., S50-S55.
18. Deck R.R., DeWitt C.M., Donnelly J.J., Liu M.A., Ulmer J.B. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine. 15:1997;71-78.
19. Kodihalli S., Haynes J.R., Robinson H.L., Webster R.G. Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J. Virol. 71:1997;3391-3396.
20. Kodihalli S., Goto H., Kobasa D.L., Krauss S., Kawaoka Y., Webster R.G. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J. Virol. 73:1999;2094-2098.
21. Fu T.M., Friedman A., Ulmer J.B., Liu M.A., Donnelly J.J. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. 71:1997;2715-2721.
22. Chen Z., Sahashi Y., Matsuo K., Asanuma H., Takahashi H., Iwasaki T., Suzuki Y., Aizawa C., Kurata T., Tamura S. Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine. 16:1998;1544-1549.
23. Chen Z., Matsuo K., Asanuma H., Takahashi H., Iwasaki T., Suzuki Y., Aizawa C., Kurata T., Tamura S. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine. 17:1999;653-659.
24. Chen Z, Yoshikawa T, Kadowaki S, Hagiwara Y, Matsuo K, Asanuma H, Aizawa C, Kurata T, Tamura S, Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein [In Process Citation], J. Gen. Virol. 1999;80,2559-64.
25. Aihara H., Miyazaki J. Gene transfer into muscle by electroporation in vivo [see comments]. Nat. Biotechnol. 16:1998;867-870.
26. Tamura S.I., Asanuma H., Ito Y., Hirabayashi Y., Suzuki Y., Nagamine T., Aizawa C., Kurata T., Oya A. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur. J. Immunol. 22:1992;477-481.
27. Tamura S., Miyata K., Matsuo K., Asanuma H., Takahashi H., Nakajima K., Suzuki Y., Aizawa C., Kurata T. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J. Immunol. 156:1996;3892-3900.
28. Potier M., Mameli L., Belisle M., Dallaire L., Melancon S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:1979;287-296.
29. Tamura S., Kurata H., Funato H., Nagamine T., Aizawa C., Kurata T. Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit. Vaccine. 7:1989;314-320.
30. Tobita K., Sugiura A., Enomote C., Furuyama M. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med. Microbiol. Immunol. (Berl.). 162:1975;9-14.
31. Tobita K. Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses. Med. Microbiol. Immunol. (Berl.). 162:1975;23-27.
32. Martinez del C. R.L., Portela A., Domingo E., Ortin J. Evolution of the influenza virus neuraminidase gene during drift of the N2 subtype. Virology. 130:1983;539-545.
33. Colman P.M., Ward C.W. Structure and diversity of influenza virus neuraminidase. Curr. Top. Microbiol. Immunol. 114:1985;177-255.
34. Harley V.R., Ward C.W., Hudson P.J. Molecular cloning and analysis of the N5 neuraminidase subtype from an avian influenza virus. Virology. 169:1989;239-243.
35. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:1996;6119-6125.
36. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278-2284.
37. Couch R.B., Kasel J.A., Gerin J.L., Schulman J.L., Kilbourne E.D. Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J. Infect. Dis. 129:1974;411-420.
38. Ogra P.L., Chow T., Beutner K.R., Rubi E., Strussenberg J., DeMello S., Rizzone C. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. J. Infect. Dis. 135:1977;499-506.
39. Johansson B.E., Moran T.M., Bona C.A., Popple S.W., Kilbourne E.D. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience. J. Immunol. 139:1987;2010-2014.
40. Johansson B.E., Bucher D.J., Kilbourne E.D. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J. Virol. 63:1989;1239-1246.
41. Johansson B.E., Kilbourne E.D. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. Virology. 225:1996;136-144.